Home » Topics » Conferences

Conferences
RSS

EM-800, a more potent antiestrogen than raloxifene in preclinical studies

July 14, 1998

New evidence supports the efficacy of PKC inhibition in diabetic neuropathy

July 14, 1998

Vitamin D analogue EB-1089 acts via effects on IGF-I

July 14, 1998

Idoxifene: another SERM with clinical potential in postmenopausal disorders

July 14, 1998

Aldose reductase inhibitor from Nippon Zoki effective in rats with diabetic neuropathy

July 13, 1998

Effects of KRP-297 on progression of diabetes in db/db mice

July 13, 1998

Effects of new SGLT inhibitor on insulin and glucose in Zucker diabetic fatty rats

July 13, 1998

M-16049 compared to troglitazone for ability to improve insulin resistance

July 13, 1998

WF10, a unique AIDS treatment alternative evaluated in the clinic

July 13, 1998

Preclinical and clinical profile of (+)-calanolide A, a novel NNRTI from a natural source

July 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...